Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00118209
First received: July 8, 2005
Last updated: September 18, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)
No publications provided by Alliance for Clinical Trials in Oncology

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):